How Much Value Would a Treatment for Alzheimer’s Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy
This is my archive
Blood-based biomarkers for Alzheimer’s pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times
Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury
Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in Canada
Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in the United States
Assessing the Preparedness of the Korean Healthcare System Infrastructure for an Alzheimer’s Treatment
Implications of Alzheimer’s Treatment for OrganizationAnd Payment of Medical Practices in the Eu-5 Countries
